The company said, “TC BioPharm (TCBP) refuted a false claim made earlier this week on social media, stating there is absolutely no way the company is in any danger of being delisted from the Nasdaq stock exchange. The since deleted rumor stated that the company had filed an 8-K Notice to ‘Delist’ from the Nasdaq and would transfer trading to a different exchange. TC BioPharm reiterated that there is no truth to this remark and that TC BioPharm remains in compliance with all Nasdaq listing requirements. The Company will look to take action to defend itself from these types of these attacks which are perpetrated in an effort to create negative market dynamics”
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCBP:
- TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes
- TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause
- TC Biopharm (Holdings) PLC – ADR trading resumes
- TC Biopharm announces artificial intelligene initiative with Carnegie Mellon
- TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial